Skip to Content

Tag: CPAP recall


Jason Jones

Specialty Providers

CPAP providers: Could that be a light at the end of the tunnel?

September 23, 2022Theresa Flaherty, Managing Editor

YARMOUTH, Maine – CPAP providers are seeing a slow rebound in business as a chokehold on orders for devices eases up, but they continue to see increased costs.  For more than a year, providers have juggled the challenges of a recall of certain CPAP devices by Philips and a subsequent shortage of available devices on the market with overall supply chain challenges affecting all manufacturers.  “Looking at my numbers from April to August, we’ve set up more CPAPs during...

CPAP Devices, CPAP recall


Read Full Articlered right arrow icon

On the Editor's Desk

When numbers speak volumes

August 24, 2022Liz Beaulieu, Editor

We recently loaded the HME Databank (www.hmedatabank.com) with 2021 data, something I’ve been keen to look at to see the impact of current dynamics in the industry, including the COVID-19 pandemic and a major CPAP recall. Let’s start with the pandemic. While we were putting together this issue, Invacare released its second quarter financial results and company officials said they expected to see reduced COVID-related demand for respiratory products in the next several quarters,...

CPAP recall, HME Databank, Pandemic


Read Full Articlered right arrow icon

Roy Jakobs

Vendors

Jakobs to take reins at Philips

August 16, 2022HME News Staff

AMSTERDAM – Roy Jakobs is expected to take the helm at Philips, succeeding Frans van Houten as CEO.  Van Houten is nearing the end of his third term as CEO.  "It has been both a privilege and a pleasure to lead the transformation of Philips, over the past 12 years, into one of the largest health technology companies in the world, bringing innovative solutions to help our customers deliver on the Quadruple Aim of better health outcomes, higher healthcare productivity and much...

CPAP recall, Frans van Houten, Philips, Roy Jakobs


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed aims to ‘lock in’ increasing market share

August 12, 2022Liz Beaulieu, Editor

SAN DIEGO – Mick Farrell’s tone has shifted slightly when it comes to ResMed increasing its market share amid a major competitor’s recall.  During a conference call to discuss the company’s fourth quarter and fiscal year 2022 financial results, the CEO said he no longer looks at it as “incremental or temporal.”  “This is permanent share taking,” he said. “We’re going to go in, we’re going to get share and we’re...

CPAP recall, CPAP Therapy, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

Philips reports declines

July 25, 2022HME News Staff

AMSTERDAM – Comparable sales for the Connected Care business at Philips decreased 13% in the second quarter of 2022, mainly due to the consequences of a major recall and supply chain headwinds.  The company says it is making progress on the recall, producing more than 3 million replacement devices and repair kits to date.  “Philips Respironics aims to further increase capacity and complete around 90% of the production and shipments to customers in 2022,” the company...

CPAP recall, Financial Results, Philips


Read Full Articlered right arrow icon

Business Development

Sleep industry grapples with shortages

May 26, 2022John Andrews

While supply chain delays have been a major choke point for the U.S. economy over the past year, the recall of Philips Respironics’ flow generators and masks has compounded the obstruction in the sleep therapy market. The ensuing vacuum created by the recall caused a ripple effect throughout the marketplace, causing various suppliers to scramble for ways to cover the shortage.  At this point, suppliers are still frustrated by a hardscrabble supply line, but remain hopeful that product...

CPAP, CPAP recall, Philips Recall, Sleep Apnea, supply chain challenges


Read Full Articlered right arrow icon

On the Editor's Desk

A fine line 

May 18, 2022Liz Beaulieu, Editor

Am I the only one getting CPAP shortage vibes from the baby formula shortage?  I’m not going to lie. The formula shortage wasn’t fully on my radar until recently. With a seven-year-old, my days of buying formula are long over. But seven years ago, it would have been a different story, as my daughter was 100% formula fed. (My breastfeeding story, by the way, is not uncommon. Difficulty with latching. Supply issues with pumping. There is no shame here.)  I can’t imagine...

Consolidation, CPAP recall, CPAP shortage


Read Full Articlered right arrow icon

Mick Farrell

Vendors

ResMed: ‘This is a humanitarian emergency’

April 29, 2022Liz Beaulieu, Editor

SAN DIEGO – ResMed has “five lines of work” to pump more of its CPAP devices into the market amid ongoing supply chain challenges, including a new AirSense 10 card-to-cloud device, says CEO Mick Farrell.  The company has launched the device – which is “basically an AirSense 10 without the cell chip in it,” says Jim Hollingshead, president, Sleep and Respiratory Care Business – only in select markets, but it’s in the process of adding markets.  “Look,...

AirSense, CPAP recall, Mick Farrell, ResMed


Read Full Articlered right arrow icon

Vendors

ResMed: ‘Our third-quarter results reflect strong performance’

April 28, 2022HME News Staff

SAN DIEGO – ResMed reported revenue increased 12% to $864.5 million in its third quarter fiscal year 2022. The company reported revenue, excluding software-as-a-service, increased 18% in the United States, Canada and Latin America, primarily due to a recall by one of its competitors and a recovery of core sleep patient flow that has been impacted by the COVID-19 pandemic. “Our third-quarter results reflect strong performance across our business, resulting in double-digit top-line...

CPAP Devices, CPAP recall, Financial Results, ResMed, Sleep Therapy


Read Full Articlered right arrow icon

Vendors

Philips increases provision for recall 

April 25, 2022HME News Staff

AMSTERDAM, the Netherlands – Philips Respironics recorded EUR 165 million in additional provisions related to its recall of certain CPAP devices in the first quarter of 2022, according to the company’s financial results.  The company recorded a EUR 65 million increase in the field action provision in the quarter to account for the higher expected volume of devices eligible for remediation and the higher communication costs. It recorded a further EUR 100 million provision...

CPAP recall, Philips Respironics


Read Full Articlered right arrow icon